The landscape of cancer treatment is undergoing a transformative shift as there is a rising demand for targeted, less toxic cancer medicines. The cancer field has seen significant advancements ...

The Trump administration is impeding the National Institutes of Health-backed science that enabled treatment of ...

A new editorial was published in , Volume 16, on March 10, 2025, titled "EXPOSOMES and GENES: The duo influencing CANCER initiation and progression." ...

Mar. 10, 2025 — Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. ... Diabetes Drug Could Help Cancer Patients Make Better Recovery ...

Hundreds of people in England with a rare form of cancer affecting the eye will soon be able to access a pioneering therapy based on T-cell receptor (TCR) technology, developed by Immunocore.

A new stem cell therapy is giving hope to patients with serious cornea injuries. This breakthrough treatment could revolutionize eye health.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Along with first-line PDL1-positive NSCLC, Libtayo is also used to treat two forms of skin cancer – cutaneous squamous cell carcinoma and basal cell carcinoma. Merck claims adjuvant win in ...